Government FCPA Enforcement “Intensely Focused” on Life Sciences Companies

more+
less-

On November 12, 2009, Lanny Breuer, Assistant Attorney General for the Criminal Division of the Department of Justice, warned that in the “months and years ahead,” the Department of Justice will focus on “the application of the Foreign Corrupt Practices Act (or "FCPA?) to the pharmaceutical industry.” Previous FCPA enforcement actions also have focused on medical device companies. Given this DOJ initiative, life sciences companies should actively review and reinvigorate their FCPA compliance efforts.

Please see full update below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Written by:

Published In:

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Morrison & Foerster LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.
×
Loading...
×
×